WHO ICTRP trial
Protease supplementation and delayed onset muscle soreness (DOMS)
ACTRN12612000467831 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12612000467831 |
|---|---|
| Public title | Protease supplementation and delayed onset muscle soreness (DOMS) |
| Scientific title | A randomised placebo controlled crossover trial to compare the effects of consumption of a protease supplement on delayed muscle soreness in healthy males. |
| Primary sponsor | University of Otago |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | New Zealand |
| Conditions | exercise-induced delayed onset muscle soreness.; exercise-induced delayed onset muscle soreness.;Diet and Nutrition - Other diet and nutrition disorders;Musculoskeletal - Normal musculoskeletal and cartilage development and function |
| Interventions | This will be a randomised, placebo-controlled, crossover study with two arms. Arm 1: Whey protein drink (500mL) with a protease enzyme (43mg). Arm 2: Whey protein drink (500mL) without the protease enzyme. This study will be carried out to… |
| Registration date | Apr 27, 2012 |
| Target size | 30 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: